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Germany.In general, atopy is defined by specific sensitization to
allergens. However, at present there is scant evidence thatallergy is central to the development of atopic dermatitis.
Despite their atopic constitution, many patients with mild
to moderate atopic dermatitis do not have clinically
relevant food or aeroallergen sensitivities; therefore, con-
troversy has surrounded the contribution of IgE-mediated
hypersensitivity to the pathogenesis of atopic dermatitis
classically belonging to the atopic diseases. Elevated blood
eosinophil counts are common in atopic dermatitis and
immigration and degranulation of activated eosinophils is
observed in lesional skin. Thus, the regulation of eosinophil
survival may represent a major mechanism through which
functional eosinophil are accumulated in inflammatory
sites. It is well known that several cytokines, including GM-
CSF, IL-5 and IL-3, are able to support eosinophil survival
and delay apoptosis. We compared eosinophil survival and
apoptosis in non-atopic volunteers and in patients with
inhalant allergy or acute exacerbation of atopic dermatitis.
In eosinophils from subjects with inhalant allergy, and
particularly with atopic dermatitis, eosinophil survival was
prolonged due to delayed apoptosis when compared to
eosinophil from non-atopic subjects (1). There was no
difference in the occurrence of apoptosis between the
extrinsic and the intrinsic type of atopic dermatitis, pointing
to a secondary role of specific sensitization. IL-34GM-
CSF4IL-5 were able to increase viability of cultured
eosinophil in non-atopics and subjects with inhalant
allergy, but were hardly able to further increase eosinophil
survival in subjects with atopic dermatitis which was
increased per se. Eosinophil supernatants of patients with
atopic dermatitis more than of patients with inhalant
allergy dose-dependently inhibited apoptosis in non-atopic
eosinophil, and it was shown by cytokine specific ELISA
that this effect was possibly due to autocrine production of
GM-CSF, probably IL-5, but not IL-3 or TGF-b1. The
observed effects in atopic dermatitis were, in fact, mediated
by an autocrine production of GM-CSF, since neutralizing
anti-GM-CSF mAbs significantly reduced atopic dermatitis
eosinophil survival. Moreover, analysing the effect of
several other cytokines on eosinophil apoptosis, IL-1b,
IL-8, IL-12, platelet activating factor, TNF-a and eotaxin
did not show any effect. However, IL-4 dose-dependently
inhibited eosinophil survival by inducing apoptosis (2). This
effect was abrogated by pre-incubation with neutralizing
anti-IL-4 antibodies and was most evident in atopic
dermatitis eosinophils. However, in co-incubation experi-
ments IL-4 did not overcome the survival-prolonging effect
of IL-3, IL-5 and GM-CSF. Moreover, IL-3, IL-5, GM-
CSF and IL-4 did not modulate eosinophil surface
expression of APO-1/Fas antigen (CD95), and Fas antigen
expression was similar between the groups studied. How-
ever, in inhalant allergy, and particularly in atopic
dermatitis, eosinophils demonstrated a certain resistance
to anti-Fas mAb induced apoptosis when compared to non-
atopic eosinophils (3). The pathomechanism of this
resistance to anti-Fas mAb as well as the mechanisms for
induction of eosinophil apoptosis in general remain
uncertain. The role of oxidative stress has not been
investigated. Thus, we next analysed the role of reactive
oxygen species and selective antioxidants in eosinophil
apoptosis. Eosinophils were cultured with the heavy metal
Fig. 1. Mucosal eosinophils may face several fates in vivo.
Black and grey arrows represent pathways for cell trac
and granule protein release, respectively. Without loosing
viability tissue eosinophils undergo piecemeal
degranulation (PMD). During active disease processes
many tissue eosinophils are ‘ultimately activated’ to
undergo eosinophil cytolysis (ECL). Viable tissue
eosinophils migrate into the airway lumen. The luminal
eosinophils are further cleared through cytolysis,
mucociliary clearance and apoptosis. However, data are
scarce on the occurrence of apoptotic eosinophils in the
airway tissue.
ABSTRACTS 1263salt sodium arsenite which presents not only a tumour
enhancer but also a potent inducer of stress responses.
Sodium arsenite is known to disturb the oxygen metabolism
in mitochondria which are major sites of reactive oxygen
production. Apart from this sodium arsenite also regulates
intracellular glutathione levels. There was a significant
increase in the rate of eosinophil apoptosis with low
concentrations of sodium arsenite whereas high concentra-
tions showed rates of apoptosis similar to control medium.
Investigating the role of intracellular oxidants by flow
cytometry we found that while inducing apoptosis sodium
arsenite more than anti-Fas mAb resulted in a significant
dose-dependent prouction of intracellular H2O2 (4). In
contrast, the extracellular release of spontaneous, receptor-
dependent (fMLP), and receptor independent stimulation
(by PMA) of the extracellular release of superoxide anion
decreased after stimulation with sodium arsenite or anti-
Fas mAb. Co-incubation experiments demonstrated that
arsenite as well as anti-Fas mAb induced apoptosis can be
nearly completely prevented by antioxidants such as
glutathione, and N-acetylcysteine but not dimethyl sulph-
oxide or taurine. Moreover, glutathione and N-acetylcys-
teine were able to significantly delay spontaneous apoptosis
in unstimulated eosinophils. Taken together these data
point to an important role of oxygen-dependent mechan-
isms and particularly of a thiol-sensitive redox system in the
regulation of eosinophil survival and apoptosis. We
propose that the level of intracellular glutathione may be
responsible for the ability of the cell to maintain an
appropriate oxidant–antioxidant balance deciding
between survival and apoptosis. Accordingly, we have
evidence for an increased intracellular glutathione content
in atopic dermatitis eosinophils which may cause the
significant delay in apoptosis and the resistance to anti-
Fas mAb when compared to eosinophils from non-atopic
donors. Further solving the puzzle of inhibited eosinophil
apoptosis will not only improve our understanding of
atopic disorders but may also have major therapeutic
implications.
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Introduction
Extensive research in vitro has produced detailed schemes of
molecular pathways controlling activation and death of
cultured eosinophil phenotypes. This molecular informa-
tion may now be contrasted by the fact that several key
questions on gross eosinophil events in vivo remain
unresolved. As exemplified below, there is an urgent need
for further demonstration and confirmation in vivo of major
modes of activation and demise of tissue eosinophils.
Once recruited to the mucosa eosinophils may be
activated to release their granule products in several distinct
ways (Fig. 1). Piecemeal degranulation (PMD) has been
described in vivo in several eosinophilic conditions. Another
event, eosinophil cytolysis (ECL), leads to extensive granule
protein release. ECL appears to be common in diseased
tissues in vivo but almost nothing is known, as yet, about its
molecular regulation. In contrast, eosinophil apoptosis
belongs to the ‘cutting edge’ in vitro research lines.
